: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Fri, 06 Nov 2009 17:26:18 GMT

Biostar Pharmaceuticals has completed a private placement that raised $3.6 million in new capital. Biostar will use the proceeds to complete its new raw materials processing facility. By taking its raw material production in house, Biostar will lower costs and ensure its product quality. Biostar plans to sell excess raw materials to other pharmaceutical companies in the Shaanxi province.[More...]

Bulls Back On Track?

Fri, 06 Nov 2009 16:21:18 GMT

Good morning. With chants of "Dow 10K… Dow 10K" once again rising from the streets at the corner of Broad and Wall yesterday, it is easy to believe that the bulls are back on track and that we'll soon be looking at new highs for the stock market. And when reviewing the data inputs to yesterday's 204 point romp, it is also easy to don the Dow10K hat once again and join in on the celebration.[More...]

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

Fri, 06 Nov 2009 13:52:50 GMT

Ford's 2,215 page 2007 master contract with the UAW 1941 UAW-Ford contract[More...]

King Beats, But Earnings Down

Thu, 05 Nov 2009 20:08:54 GMT

King Pharmaceuticals, Inc. (KG) reported third quarter earnings of 29 cents per share, beating the Zacks Consensus Estimate by 2 cents. Despite revenues increasing 19.3% from the year-ago period, earnings declined 25.6% from the year-ago quarter mainly due to higher operating expenses.[More...]

Your Kind of Day?

Thu, 05 Nov 2009 19:06:48 GMT

As a rule, I try not to read too terribly much into a "Fed Day" as there is usually a big batch of volatility that may or may not mean much of anything come the dawn of the next day. Maybe, it's just me. Or maybe there are others that find themselves inclined to simply stand aside and watch the nuttiness from the sidelines on "Fed Days." But in any event, the volatility after a Fed announcement, while fun to watch, may not be telling as to what to expect in the future.[More...]

The Dollar-Proof Portfolio

Thu, 05 Nov 2009 17:31:14 GMT

Don't put off this important piece of the financial-planning process.[More...]

What Investors Should Look for In Today’s Fed Statement

Wed, 04 Nov 2009 13:04:24 GMT

In its continuing efforts to nurture the fragile economic recovery, the U.S. Federal Reserve is widely expected to leave interest rates at record lows when it concludes its meeting today (Wednesday).[More...]

Are Discount Brokers Shares Worth Owning?

Wed, 04 Nov 2009 01:28:03 GMT

The third quarter was a favorable one for the longs. Except for a few short-lived, minor pullbacks stock prices moved higher through the quarter. Stock price volatility declined, takeover activity rose, and risk appetite improved to help the S&P gain 15%.[More...]

Options Intelligence Report: High Energy Rewards For Option Trader At RRI

Tue, 03 Nov 2009 18:20:31 GMT

Today's tickers: RRI, WFR, CAR, FRX, SWK, BNI & WFR[More...]

Neurogen Corp. reports $1.9M loss, sells real estate

Sat, 07 Nov 2009 16:46:00 GMT

Nov. 7--BRANFORD -- Neurogen Corp., which is being acquired by a San Diego company in a deal that will close its local operations, on Friday reported its latest financial earnings and said it has sold its headquarters at 45 N.E. Industrial Road to a commercial real estate developer.
The company, founded in 1987, announced in August it would be acquired by Ligand Pharmaceuticals Inc., a California company that will not maintain a presence in town.
The deal is expected to close this quarter.

: iStockAnalyst.com Symbols Feed

Biostar Raises $3.6 Million

Bulls Back On Track?

Ford's Main Problem: The UAW's Crippling Job Classifications And Work Rules

King Beats, But Earnings Down

Your Kind of Day?

The Dollar-Proof Portfolio

What Investors Should Look for In Today’s Fed Statement

Are Discount Brokers Shares Worth Owning?

Options Intelligence Report: High Energy Rewards For Option Trader At RRI

Neurogen Corp. reports $1.9M loss, sells real estate

Targacept has profit in quarter: Large milestone payment by AstraZeneca credited for first profit in almost three years

Auditor: Canada disaster planning is poor

Vaccine-short Canada exporting 'surplus'

Largest malaria vaccine trial under way

State AGs suing U.S. drug maker Amgen

Business Highlights

Canada's H1N1 flu vaccine running short

GlaxoSmithKline third quarter profit up 11 percent

FDA OK's new leukemia treatment

Cytokinetics Announces Addition to Board of Directors

ConocoPhillips up 21% Since Added to Galtstock Long-Term Portfolio

NPS Pharmaceuticals Reports Third Quarter Results and Improved Cash Burn Guidance

Phase Forward Reports Third Quarter 2009 Results

AstraZeneca: Third Quarter and Nine Months Results 2009

Ligand to Acquire Metabasis for Cash and Contingent Value Rights

Procter &Amp; Gamble Co. Up 13% Since Added to Galtstock Long Portfolio

Bristol-Myers Squibb Achieves Strong Sales, Earnings Performance in Third Quarter

Licensing Executives Society Announces 2009 Deals of Distinction Awards

PicksThatMove.Com Announces Investment Opinion: Hot Stocks That Are on the Move

Form 4 RICHO ANNA For: Nov 05 (10K)

Form 4 BONANNI FABRIZIO For: Nov 05 (10K)

Form 4 SHARER KEVIN W For: Nov 05 (10K)

Form 4 BARBIER REMI For: Nov 02 (10K)

Form 4 HOOVER R DAVID For: Oct 30 (10K)

Form 4 Fyrwald J Erik For: Oct 30 (10K)

Form 4 PAIN THERAPEUTICS INC For: Oct 15 Filed by: ROBERTSON SANFORD (10K)

Form 4 BARBIER REMI For: Oct 05 (10K)

Form 4 BARBIER REMI For: Oct 01 (10K)

Form 4 OMENN GILBERT S For: Sep 28 (10K)